Average Co-Inventor Count = 5.16
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ptc Therapeutics, Inc. (9 from 184 patents)
2. Wyeth (6 from 1,309 patents)
15 patents:
1. 9593108 - Compounds and methods for antiviral treatment
2. 9351964 - Methods for treating cancer and non-neoplastic conditions
3. 9271960 - Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
4. 8946444 - Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control
5. 8940896 - Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis
6. 8372860 - Carboline derivatives useful in the inhibition of angiogenesis
7. 8367694 - Carboline derivatives useful in the inhibition of angiogenesis
8. 7767689 - Carboline derivatives useful in the treatment of cancer
9. 7601840 - Carboline derivatives useful in the inhibition of angiogenesis
10. 7585876 - Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
11. 7297705 - Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
12. 7022701 - Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
13. 6903112 - Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
14. 6800640 - Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
15. 6770642 - Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands